Selecting patients for idarucizumab (‘Praxbind’)


2 Nov 2016

In the final video of the series Professor Pollack takes us through interim results from RE-VERSE AD which identified the types of patients suitable for dabigatran reversal with idarucizumab (Praxbind).


Already a member?

Login to keep reading.

Email me a login link